GGrantIndex
Sort

34,240 grants matching atherosclerosis

Hopkins Lupus Cohort

$673,347
Michelle A Petri · Johns Hopkins University · R01 · FY2020 · AR

Combined OCT/US/PAT system for intravascular Imaging

$673,202
Zhongping Chen · University Of California-Irvine · R01 · FY2018 · HL

Multifunctional nanoformulations for diagnostic imaging of atherosclerosis

$673,165
Alexander B Sigalov · Signablok, Inc. · R44 · FY2015 · HL

AMPK Regulation of ACE2 in Endothelial Health and Disease

$673,114
John Y-J Shyy · University Of California, San Diego · R01 · FY2023 · HL

Circulating hydrogen sulfide, diabetes and diabetes-related cardiovascular disease

$673,106
Rheem Angela Totah · University Of Washington · R01 · FY2022 · HL

Dietary Mitigation of Psychosocial Stress Effects on CVD Risk

$673,077
Carol A. Shively · Wake Forest University Health Sciences · R01 · FY2013 · HL

Multi-Scale Biology of Atherosclerosis in the Cellular Adhesion Pathway

$673,030
Suzette Janine Bielinski · Mayo Clinic Rochester · R01 · FY2010 · HL

The Biology of VWF Self-Association

$672,991
Dominic W. Chung · Bloodworks · R01 · FY2019 · HL

The Biology of VWF Self-Association

$672,991
Dominic W. Chung · Bloodworks · R01 · FY2017 · HL

Helicobacter pylori infection and endothelial dysfunction

$672,977
Zhenguo Liu · University Of Missouri-Columbia · R01 · FY2019 · HL

Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly

$672,858
Amil M Shah · Ut Southwestern Medical Center · R01 · FY2024 · HL

Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap

$672,817
Gary K Owens · University Of Virginia · R01 · FY2022 · HL

Stress-induced trained immunity in cardiovascular disease

$672,799
Mandy Maria Theresia Van Leent · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · HL

Novel Regulators of Calcific Aortic Valve Disease

$672,764
Mehran M Sadeghi · Yale University · R01 · FY2017 · HL

Inactivity, sedentary behavior, and the risk for Alzheimer’s disease in middle aged to older adults

$672,662
David Raichlen · University Of Southern California · R01 · FY2024 · AG

Age, GenelEnvironment Susceptibility-Reykjavik Study Continuation

$672,582
Vilmundur Gudnason · Icelandic Heart Association · N01 · FY2015 · AG

Contributions of pulmonary arterial and venous remodeling to HFpEF in the elderly

$672,558
Amil M Shah · Ut Southwestern Medical Center · R01 · FY2025 · HL

Plaque and blood derived macrophages: a multi-omic assessment of CVD pathogenesis in PLWH

$672,498
Nicholas T. Funderburg · Ohio State University · R01 · FY2024 · HL

The Intracranial Atherosclerotic Disease and Cognitive Impairment Study

$672,444
Bruce A Wasserman · Johns Hopkins University · R01 · FY2013 · HL

Predictors of Coronary Artery Calcification in an African-American Cohort

$672,439
Patricia Peyser · University Of Michigan At Ann Arbor · R01 · FY2010 · HL

Cardiac Toxicity in Perinatally HIV-Infected Adolescents and Young Adults, a Longitudinal Study

$672,429
Steven Edward Lipshultz · State University Of New York At Buffalo · R01 · FY2020 · HL

Gestational diabetes phenotypes, glucose tolerance transitions and lifestyle behaviors related to cardiovascular risk status

$672,244
Nisha Indravadan Parikh · University Of California, San Francisco · R56 · FY2019 · HL

The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study

$672,085
Danxia Yu · Vanderbilt University Medical Center · R01 · FY2024 · DK

Diabetes and Prediabetes in Older Adults in ARIC

$672,056
Elizabeth Selvin · Johns Hopkins University · R01 · FY2017 · DK

Development, testing, and implementation of virtual statin associated muscle symptom (SAMS) management

$672,046
Jordan Bradley King · University Of Utah · R01 · FY2021 · HL